Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

BPH management needs better long-term studies and prevention strategies.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Large prostate patients more likely to have hair loss.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Purple corn extract may help reduce prostate enlargement and inflammation.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

A bladder rupture from prostate treatment was healed with catheterization and antibiotics.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Big chain pharmacies in Pennsylvania charge significantly more for generic BPH medications than independent pharmacies, but independent pharmacies have more regional price variation.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.